Supplementary Table 1 from Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

<p>Drug Screening Data</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Gerhard Jungwirth (15047922) (author)
Daljnji autori:	Tao Yu (15047925) (author), Fang Liu (15047928) (author), Junguo Cao (15047931) (author), Montadar Alaa Eddine (15047934) (author), Mahmoud Moustafa (15047937) (author), Amir Abdollahi (15026702) (author), Rolf Warta (15047940) (author), Andreas Unterberg (15047943) (author), Christel Herold-Mende (15047946) (author)
Izdano:	2025
Teme:	Cancer Therapeutic Research and Development CNS Cancers Small Molecule Agents Translational Research
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti